- TTX-810 is designed for rapid clearance to circumvent mechanism-based risks of MCL1 inhibition - High potency affords robust anti-tumor effects whilst preserving cardiomyocyte viability - Trueline
- Key C-suite appointments provide fiscal and culture leadership as company expandsCAMBRIDGE, Mass. (BUSINESS WIRE) Anji Pharma, an emerging global medicines company, today announced an expanded leadership team with the appointments of Julianne Averill as Chief Financial Officer and Kristen Richardson as Chief Peo.